Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.78 USD | +4.31% | +2.84% | -48.91% |
05:05pm | Canaccord Genuity Adjusts Price Target on 10x Genomics to $50 From $65, Maintains Buy Rating | MT |
04-18 | Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating | MT |
Business Summary
Number of employees: 1,259
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Consumables
77.5
%
| 436 | 84.3 % | 480 | 77.5 % | +10.09% |
Instruments
20.0
%
| 72 | 14.0 % | 123 | 20.0 % | +70.55% |
Services
2.5
%
| 8 | 1.6 % | 16 | 2.5 % | +86.39% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
58.2
%
| 285 | 55.2 % | 360 | 58.2 % | +26.35% |
Europe, Middle East and Africa
23.0
%
| 117 | 22.7 % | 142 | 23.0 % | +21.53% |
Asia Pacific (excluding China)
8.5
%
| 46 | 8.9 % | 52 | 8.5 % | +13.67% |
China
8.2
%
| 60 | 11.5 % | 51 | 8.2 % | -14.43% |
Americas (excluding United States)
2.1
%
| 9 | 1.7 % | 13 | 2.1 % | +49.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Serge Saxonov
FOU | Founder | 47 | 12-07-01 |
Ben Hindson
FOU | Founder | 49 | 12-07-01 |
Justin McAnear
DFI | Director of Finance/CFO | 49 | 18-09-30 |
Chief Tech/Sci/R&D Officer | - | 12-12-31 | |
Rebecca Port
HRO | Human Resources Officer | - | 20-12-31 |
General Counsel | 56 | 17-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Stuelpnagel
CHM | Chairman | 66 | 13-07-31 |
Kim Popovits
BRD | Director/Board Member | 65 | 20-03-25 |
Mathai Mammen
BRD | Director/Board Member | 57 | 17-08-22 |
Ben Hindson
FOU | Founder | 49 | 12-07-01 |
Serge Saxonov
FOU | Founder | 47 | 12-07-01 |
Sridhar Kosaraju
BRD | Director/Board Member | 46 | 19-02-28 |
Shehnaaz Suliman
BRD | Director/Board Member | 52 | 19-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 14,056,833 | 0 | 0 | 85.50 % |
Stock B | 1 | 105,109,711 | 101,887,497 ( 96.93 %) | 0 |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.91% | 3.3B | |
+1.49% | 12.8B | |
-10.29% | 7.61B | |
+3.22% | 5.41B | |
-1.16% | 4.51B | |
+7.56% | 4.49B | |
+12.21% | 2.73B | |
-14.64% | 2.02B | |
-11.50% | 1.73B | |
-0.16% | 1.64B |
- Stock Market
- Equities
- TXG Stock
- Company 10x Genomics, Inc.